Ursa Brown-Glaberman
Expertise in
13
conditions

Dr. Ursa Brown-Glaberman

Oncology
Christus St Vincent Medical Oncology
2237 Trinity Dr Ste B, 
Los Alamos, NM 
Accepting New Patients
Referral required
Before you request
Expertise in
13
conditions
Christus St Vincent Medical Oncology
2237 Trinity Dr Ste B, 
Los Alamos, NM 

Overview

Ursa Brown-Glaberman is an Oncologist practicing medicine in Los Alamos, New Mexico.

Dr. Brown-Glaberman is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Brown-Glaberman is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 34 clinical trials. Dr. Brown-Glaberman is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in AZ

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Arizona

Hospital Affiliations

Unm Hospital
Holy Cross Hospital A Div Of Taos Health Systems
Christus St Vincent Regional Medical Center

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 7 Less Insurance Carriers -

Locations

Christus St Vincent Medical Oncology
2237 Trinity Dr Ste B, Los Alamos, NM 87544
Other Locations
Christus St Vincent Medical Oncologists
490 W Zia Rd Ste 210, Santa Fe, NM 87505

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

34 Clinical Trials

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Enrollment Status: Active_not_recruiting
Publish Date: September 04, 2026
Intervention Type: Other, Procedure
Study Phase: Phase 3
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Drug
Study Drugs: Endoxifen Hydrochloride, Tamoxifen Citrate
Study Phase: Phase 2
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: Capecitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Other, Procedure
Study Phase: Phase 2
A Randomized, Phase II Trial of Circulating Tumor DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
A Randomized, Phase II Trial of Circulating Tumor DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Palbociclib, Fulvestrant, Adjuvant Therapy
Study Phase: Phase 2
EROS: Engendering Reproductive Health Within Oncologic Survivorship
EROS: Engendering Reproductive Health Within Oncologic Survivorship
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2026
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

36 Total Publications

Move Toward Recovery: A Feasibility Study for a Physical Activity Intervention to Reduce Post-Surgical Pain in Young Hispanic Breast Cancer Patients.
Move Toward Recovery: A Feasibility Study for a Physical Activity Intervention to Reduce Post-Surgical Pain in Young Hispanic Breast Cancer Patients.
Journal: International journal of environmental research and public health
Published: June 25, 2026
Similar Doctors
Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

Northern New Mexico Cancer Care

3917 West Rd Ste 225, 
Los Alamos, NM 
 (0.1 miles away)
505-662-3450
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Karen Russo is an Oncologist practicing medicine in Los Alamos, New Mexico. Dr. Russo is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer. Dr. Russo is board certified in American Board Of Internal Medicine. Dr. Russo is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Office

2400 Unser Blvd SE Ste 28300, 
Rio Rancho, NM 
 (48.4 miles away)
505-843-7813
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Karen Finkelstein is an Oncologist practicing medicine in Rio Rancho, New Mexico. Dr. Finkelstein is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Finkelstein is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Christus St. Vincent Medical Oncologists

445 Saint Michaels Dr, 
Santa Fe, NM 
 (23.1 miles away)
505-913-8900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Atul Kumar is an Oncologist practicing medicine in Santa Fe, New Mexico. Dr. Kumar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Thrombectomy. Dr. Kumar is board certified in American Board Of Internal Medicine. Dr. Kumar is currently accepting new patients.

Frequently Asked Questions about Dr. Ursa Brown-Glaberman

How do I make an appointment with Dr. Ursa Brown-Glaberman?

You can book an appointment with Dr. Ursa Brown-Glaberman by calling their office at 505-662-8870. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ursa Brown-Glaberman a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ursa Brown-Glaberman is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ursa Brown-Glaberman specialize in?

While Dr. Ursa Brown-Glaberman is a Oncology, they have specific expertise in Breast Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Ursa Brown-Glaberman participate in research or clinical trials?

Yes. Dr. Ursa Brown-Glaberman has published 36 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Ursa Brown-Glaberman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ursa Brown-Glaberman accept my insurance?

Dr. Ursa Brown-Glaberman accepts most major insurance plans, including Anthem BCBS and Cigna. We recommend calling the office directly at 505-662-8870 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brown-Glaberman's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile